Staphylococcus aureus DSM 6247 is an aerobe, mesophilic human pathogen of the family Staphylococcaceae.
aerobe mesophilic human pathogen| @ref 20215 |
Last LPSN update
2025-12-16 09:50:21 |
| Domain Bacillati |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 2554 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive  | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| 59547 | Oxygen toleranceaerobe |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68375 | 22599 ChEBI | arabinose | - | fermentation | from API ID32STA |
| 68375 | 29016 ChEBI | arginine | + | hydrolysis | from API ID32STA |
| 68375 | 17057 ChEBI | cellobiose | - | fermentation | from API ID32STA |
| 68375 | 15824 ChEBI | D-fructose | + | fermentation | from API ID32STA |
| 68375 | 17634 ChEBI | D-glucose | + | fermentation | from API ID32STA |
| 68375 | 16899 ChEBI | D-mannitol | + | fermentation | from API ID32STA |
| 68375 | 16024 ChEBI | D-mannose | + | fermentation | from API ID32STA |
| 68375 | 4853 ChEBI | esculin | - | hydrolysis | from API ID32STA |
| 68375 | 17716 ChEBI | lactose | + | fermentation | from API ID32STA |
| 68375 | 17306 ChEBI | maltose | + | fermentation | from API ID32STA |
| 68375 | 59640 ChEBI | N-acetylglucosamine | + | fermentation | from API ID32STA |
| 68375 | 17632 ChEBI | nitrate | + | reduction | from API ID32STA |
| 68375 | 18257 ChEBI | ornithine | - | degradation | from API ID32STA |
| 68375 | 16634 ChEBI | raffinose | - | fermentation | from API ID32STA |
| 68375 | 17992 ChEBI | sucrose | + | fermentation | from API ID32STA |
| 68375 | 27082 ChEBI | trehalose | + | fermentation | from API ID32STA |
| 68375 | 32528 ChEBI | turanose | + | fermentation | from API ID32STA |
| 68375 | 16199 ChEBI | urea | + | hydrolysis | from API ID32STA |
| @ref | Chebi-ID | Metabolite | Production | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | from API ID32STA |
| @ref | Chebi-ID | Metabolite | Voges-proskauer-test | |
|---|---|---|---|---|
| 68375 | 15688 ChEBI | acetoin | + | from API ID32STA |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68375 | alkaline phosphatase | + | 3.1.3.1 | from API ID32STA |
| 68375 | arginine dihydrolase | + | 3.5.3.6 | from API ID32STA |
| 68375 | beta-galactosidase | - | 3.2.1.23 | from API ID32STA |
| 68375 | beta-glucosidase | - | 3.2.1.21 | from API ID32STA |
| 68375 | beta-glucuronidase | - | 3.2.1.31 | from API ID32STA |
| 68375 | L-arginine arylamidase | - | from API ID32STA | |
| 68375 | ornithine decarboxylase | - | 4.1.1.17 | from API ID32STA |
| 68375 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API ID32STA |
| 68375 | urease | + | 3.5.1.5 | from API ID32STA |
| @ref | URE | ADH (Arg) | ODC | ESC | GLU | FRU | MNE | MAL | LAC | TRE | MAN | RAF | RIB | CEL | Reduction of nitrateNIT | Acetoin production (Voges Proskauer test)VP | beta GAL | L-arginine arylamidaseArgA | PAL | Pyrrolidonyl arylamidasePyrA | NOVO | SAC | NAG | TUR | ARA | beta GUR | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59547 | + | + | - | - | + | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | - | + | + | + | - | - | |
| 2554 | + | + | - | - | + | + | + | + | + | + | + | - | + | - | + | + | - | - | + | - | + | + | + | + | - | - |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Biotechnology | Validation of the Peel Plate Staphylococcus Aureus (SA) Test for Enumeration of S. aureus in Selected Foods and Non-Cultured Dairy Products: AOAC Performance Tested MethodSM 082401. | Salter RS, Durbin GW, Li S, Gilbert M, Crowley ES, Deterding A, Bastin B. | J AOAC Int | 10.1093/jaoacint/qsae083 | 2025 | |
| Functional Effects of ARV-1502 Analogs Against Bacterial Hsp70 and Implications for Antimicrobial Activity. | Brakel A, Kolano L, Kraus CN, Otvos L, Hoffmann R. | Front Chem | 10.3389/fchem.2022.798006 | 2022 | | |
| Pathogenicity | Ribosomal Target-Binding Sites of Antimicrobial Peptides Api137 and Onc112 Are Conserved among Pathogens Indicating New Lead Structures To Develop Novel Broad-Spectrum Antibiotics. | Kolano L, Knappe D, Volke D, Strater N, Hoffmann R. | Chembiochem | 10.1002/cbic.202000109 | 2020 | |
| Effect of Amino Acid Substitutions on 70S Ribosomal Binding, Cellular Uptake, and Antimicrobial Activity of Oncocin Onc112. | Kolano L, Knappe D, Berg A, Berg T, Hoffmann R. | Chembiochem | 10.1002/cbic.202100609 | 2022 | | |
| Intracellular toxicity of proline-rich antimicrobial peptides shuttled into mammalian cells by the cell-penetrating peptide penetratin. | Hansen A, Schafer I, Knappe D, Seibel P, Hoffmann R. | Antimicrob Agents Chemother | 10.1128/aac.00585-12 | 2012 | | |
| Synthesis, Bacteriostatic and Anticancer Activity of Novel Phenanthridines Structurally Similar to Benzo[c]phenanthridine Alkaloids. | Lasak P, Motyka K, Krystof V, Styskala J. | Molecules | 10.3390/molecules23092155 | 2018 | | |
| Natural Products from Actinobacteria Associated with Fungus-Growing Termites. | Benndorf R, Guo H, Sommerwerk E, Weigel C, Garcia-Altares M, Martin K, Hu H, Kufner M, de Beer ZW, Poulsen M, Beemelmanns C. | Antibiotics (Basel) | 10.3390/antibiotics7030083 | 2018 | | |
| Griseolutein T from Streptomyces seoulensis, newly identified via combined-culture with Tsukamurella pulmonis, as an efficacious therapeutic agent against multidrug-resistant bacteria. | Kawai SJ, Asamizu S, Suzuki H, Onaka H, Arakawa Y, Kimura K, Ojika M. | J Antibiot (Tokyo) | 10.1038/s41429-025-00846-3 | 2025 | | |
| Secondary Metabolites of Fomitopsis betulina: Chemical Structures, Biological Activity and Application Prospects. | Li J, Li Z, Duan Y, Liu C, Yan M. | J Fungi (Basel) | 10.3390/jof10090616 | 2024 | | |
| Proteome | Phytochemical Characterization of Water Avens (Geum rivale L.) Extracts: Structure Assignment and Biological Activity of the Major Phenolic Constituents. | Orlova A, Kysil E, Tsvetkova E, Meshalkina D, Whaley A, Whaley AO, Laub A, Francioso A, Babich O, Wessjohann LA, Mosca L, Frolov A, Povydysh M. | Plants (Basel) | 10.3390/plants11212859 | 2022 | |
| First Insight into the Neuroprotective and Antibacterial Effects of Phlorotannins Isolated from the Cell Walls of Brown Algae Fucus vesiculosus and Pelvetia canaliculata. | Meshalkina D, Tsvetkova E, Orlova A, Islamova R, Grashina M, Gorbach D, Babakov V, Francioso A, Birkemeyer C, Mosca L, Tarakhovskaya E, Frolov A. | Antioxidants (Basel) | 10.3390/antiox12030696 | 2023 | | |
| Metabolism | Biosynthesis and Mechanism of Action of the Cell Wall Targeting Antibiotic Hypeptin. | Wirtz DA, Ludwig KC, Arts M, Marx CE, Krannich S, Barac P, Kehraus S, Josten M, Henrichfreise B, Muller A, Konig GM, Peoples AJ, Nitti A, Spoering AL, Ling LL, Lewis K, Crusemann M, Schneider T. | Angew Chem Int Ed Engl | 10.1002/anie.202102224 | 2021 | |
| Efficacy of Phage- and Bacteriocin-Based Therapies in Combatting Nosocomial MRSA Infections. | Walsh L, Johnson CN, Hill C, Ross RP. | Front Mol Biosci | 10.3389/fmolb.2021.654038 | 2021 | | |
| Antimicrobial potentials of natural products against multidrug resistance pathogens: a comprehensive review. | Elmaidomy AH, Shady NH, Abdeljawad KM, Elzamkan MB, Helmy HH, Tarshan EA, Adly AN, Hussien YH, Sayed NG, Zayed A, Abdelmohsen UR. | RSC Adv | 10.1039/d2ra04884a | 2022 | | |
| Silver Nanoparticles Functionalized With Antimicrobial Polypeptides: Benefits and Possible Pitfalls of a Novel Anti-infective Tool. | Zharkova MS, Golubeva OY, Orlov DS, Vladimirova EV, Dmitriev AV, Tossi A, Shamova OV. | Front Microbiol | 10.3389/fmicb.2021.750556 | 2021 | | |
| Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs. | Kopeikin PM, Zharkova MS, Kolobov AA, Smirnova MP, Sukhareva MS, Umnyakova ES, Kokryakov VN, Orlov DS, Milman BL, Balandin SV, Panteleev PV, Ovchinnikova TV, Komlev AS, Tossi A, Shamova OV. | Front Cell Infect Microbiol | 10.3389/fcimb.2020.552905 | 2020 | | |
| Pathogenicity | Anti-bacterial activities and phytochemical screening of extracts of different parts of Thalictrum rhynchocarpum. | Mayeku PW, Hassanali A, Kiremire BT, Odalo JO, Hertweck C. | Afr J Tradit Complement Altern Med | 10.4314/ajtcam.v10i5.20 | 2013 | |
| Studies at the ionizable position of cephalosporins and penicillins: hydroxamates as substitutes for the traditional carboxylate group. | Majewski MW, Miller PA, Miller MJ. | J Antibiot (Tokyo) | 10.1038/ja.2016.149 | 2017 | | |
| Metabolism | Secondary Metabolites and Their Bioactivities Produced by Paecilomyces. | Dai ZB, Wang X, Li GH. | Molecules | 10.3390/molecules25215077 | 2020 | |
| Selected Fungal Natural Products with Antimicrobial Properties. | Jakubczyk D, Dussart F. | Molecules | 10.3390/molecules25040911 | 2020 | | |
| Application of bacteriocins in food preservation and infectious disease treatment for humans and livestock: a review. | Ng ZJ, Zarin MA, Lee CK, Tan JS. | RSC Adv | 10.1039/d0ra06161a | 2020 | | |
| Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction. | Ji C, Lin W, Moraski GC, Thanassi JA, Pucci MJ, Franzblau SG, Mollmann U, Miller MJ. | Bioorg Med Chem | 10.1016/j.bmc.2012.04.026 | 2012 | | |
| Genetics | Herpetopanone, a diterpene from Herpetosiphon aurantiacus discovered by isotope labeling. | Pan X, Domin N, Schieferdecker S, Kage H, Roth M, Nett M. | Beilstein J Org Chem | 10.3762/bjoc.13.242 | 2017 | |
| Metabolism | Siderophore-fluoroquinolone conjugates containing potential reduction-triggered linkers for drug release: synthesis and antibacterial activity. | Ji C, Miller MJ. | Biometals | 10.1007/s10534-015-9830-3 | 2015 | |
| Indole alkaloids from marine sources as potential leads against infectious diseases. | Franca PH, Barbosa DP, da Silva DL, Ribeiro EA, Santana AE, Santos BV, Barbosa-Filho JM, Quintans JS, Quintans JS, Barreto RS, Quintans-Junior LJ, de Araujo-Junior JX. | Biomed Res Int | 10.1155/2014/375423 | 2014 | | |
| Siderophore-Antibiotic Conjugate Design: New Drugs for Bad Bugs? | Negash KH, Norris JKS, Hodgkinson JT. | Molecules | 10.3390/molecules24183314 | 2019 | | |
| Enzymology | Secondary Metabolites, Biological Activities, and Industrial and Biotechnological Importance of Aspergillus sydowii. | Ibrahim SRM, Mohamed SGA, Alsaadi BH, Althubyani MM, Awari ZI, Hussein HGA, Aljohani AA, Albasri JF, Faraj SA, Mohamed GA. | Mar Drugs | 10.3390/md21080441 | 2023 | |
| Design, synthesis, and study of a mycobactin-artemisinin conjugate that has selective and potent activity against tuberculosis and malaria. | Miller MJ, Walz AJ, Zhu H, Wu C, Moraski G, Mollmann U, Tristani EM, Crumbliss AL, Ferdig MT, Checkley L, Edwards RL, Boshoff HI. | J Am Chem Soc | 10.1021/ja109665t | 2011 | | |
| Metabolism | Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors. | Muller A, Munch D, Schmidt Y, Reder-Christ K, Schiffer G, Bendas G, Gross H, Sahl HG, Schneider T, Brotz-Oesterhelt H. | J Biol Chem | 10.1074/jbc.m112.369561 | 2012 | |
| Metabolism | Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers. | Ji C, Miller MJ. | Bioorg Med Chem | 10.1016/j.bmc.2012.04.034 | 2012 | |
| Antimicrobial histones and DNA traps in invertebrate immunity: evidences in Crassostrea gigas. | Poirier AC, Schmitt P, Rosa RD, Vanhove AS, Kieffer-Jaquinod S, Rubio TP, Charriere GM, Destoumieux-Garzon D. | J Biol Chem | 10.1074/jbc.m114.576546 | 2014 | | |
| Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. | Limbert M, Isert D, Klesel N, Markus A, Seeger K, Seibert G, Schrinner E. | Antimicrob Agents Chemother | 10.1128/aac.35.1.14 | 1991 | | |
| Metabolism | femA, which encodes a factor essential for expression of methicillin resistance, affects glycine content of peptidoglycan in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains. | Maidhof H, Reinicke B, Blumel P, Berger-Bachi B, Labischinski H. | J Bacteriol | 10.1128/jb.173.11.3507-3513.1991 | 1991 | |
| Pathogenicity | Characterization of reutericyclin produced by Lactobacillus reuteri LTH2584. | Ganzle MG, Holtzel A, Walter J, Jung G, Hammes WP. | Appl Environ Microbiol | 10.1128/aem.66.10.4325-4333.2000 | 2000 | |
| Metabolism | Influence of femB on methicillin resistance and peptidoglycan metabolism in Staphylococcus aureus. | Henze U, Sidow T, Wecke J, Labischinski H, Berger-Bachi B. | J Bacteriol | 10.1128/jb.175.6.1612-1620.1993 | 1993 | |
| Cell surface antigen of encapsulated Staphylococcus epidermidis ATCC 31432. | Ohshima Y, Ichiman Y, Usui Y, Ko HL, Beuth J, Pulverer G, Yoshida K. | J Clin Microbiol | 10.1128/jcm.25.7.1338-1340.1987 | 1987 | | |
| [Suitability of chemical neutralizers applied for disinfection control on commercial animal husbandry objects]. | Bineva I, Karadzhov S. | Vet Med Nauki | 1979 | | ||
| [On the bactericidal action of dibromoisocyanuric acid; experiments concerning the disinfection of hands (author's transl)]. | Gottardi W, Puritscher M. | Zentralbl Bakteriol Orig B | 1976 | | ||
| Pathogenicity | Fan-shaped ejections of regularly arranged murosomes involved in penicillin-induced death of staphylococci. | Giesbrecht P, Kersten T, Wecke J. | J Bacteriol | 10.1128/jb.174.7.2241-2252.1992 | 1992 | |
| [Cultural analysis of Staphylococcus aureus hemolyticus SG 511]. | HACKENTHAL H, BIERKOWSKI E. | Zentralbl Bakteriol Orig | 1955 | | ||
| Metabolism | sn-Glycerol-3-phosphate dehydrogenase and its interaction with nitrate reductase in wild-type and hem mutant strains of Staphylococcus aureus. | Lascelles J. | J Bacteriol | 10.1128/jb.133.2.621-625.1978 | 1978 | |
| Metabolism | Reduction of ferric iron by L-lactate and DL-glycerol-3-phosphate in membrane preparations from Staphylococcus aureus and interactions with the nitrate reductase system. | Lascelles J, Burke KA. | J Bacteriol | 10.1128/jb.134.2.585-589.1978 | 1978 | |
| Biotechnology | Death of Staphylococcus aureus in liquid whole egg near pH 8. | Ng H, Garibaldi JA. | Appl Microbiol | 10.1128/am.29.6.782-786.1975 | 1975 | |
| Enzymology | Nitrate reductase activity in heme-deficient mutants of Staphylococcus aureus. | Burke KA, Lascelles J. | J Bacteriol | 10.1128/jb.126.1.225-231.1976 | 1976 | |
| Metabolism | Uptake of indolmycin in gram-positive bacteria. | Werner RG. | Antimicrob Agents Chemother | 10.1128/aac.18.6.858 | 1980 | |
| Enzymology | Nitrate reductase system in Staphylococcus aureus wild type and mutants. | Burke KA, Lascelles J. | J Bacteriol | 10.1128/jb.123.1.308-316.1975 | 1975 | |
| Pathogenicity | Antimicrobial activities of 81.723 hfu, a new pleuromutilin derivative. | Drews J, Georgopoulos A, Laber G, Schutze E, Unger J. | Antimicrob Agents Chemother | 10.1128/aac.7.5.507 | 1975 | |
| Pathogenicity | Susceptibility of Bacterium actinomycetem comitans to 45 antibiotics. | Hoffler U, Niederau W, Pulverer G. | Antimicrob Agents Chemother | 10.1128/aac.17.6.943 | 1980 | |
| Pathogenicity | Structure-activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl esters. | Moraski GC, Chang M, Villegas-Estrada A, Franzblau SG, Mollmann U, Miller MJ. | Eur J Med Chem | 10.1016/j.ejmech.2009.12.074 | 2010 | |
| Metabolism | Reduction of iron and synthesis of protoheme by Spirillum itersonii and other organisms. | Dailey HA, Lascelles J. | J Bacteriol | 10.1128/jb.129.2.815-820.1977 | 1977 | |
| Pathogenicity | Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species. | Hoeffler U, Ko HL, Pulverer G. | Antimicrob Agents Chemother | 10.1128/aac.10.3.387 | 1976 | |
| Screening, fermentation, isolation, and chracterization of trypanomycin, a new antibiotic. | Fleck W, Strauss D, Schonfeld C, Jungstand W, Seeber C, Prauser H. | Antimicrob Agents Chemother | 10.1128/aac.1.5.385 | 1972 | | |
| Metabolism | Biosynthesis of hematin compounds in a hemin requiring strain of Micrococcus pyogenes var. aureus. I. The significance of coenzyme A for the terminal synthesis of catalase. | JENSEN J. | J Bacteriol | 10.1128/jb.73.3.324-333.1957 | 1957 | |
| The hypersusceptible antibiotic screening strain Staphylococcus aureus SG511-Berlin harbors multiple mutations in regulatory genes. | Dietrich A, Steffens U, Sass P, Bierbaum G | Int J Med Microbiol | 10.1016/j.ijmm.2021.151545 | 2021 | | |
| Metabolism | A plant endophyte Staphylococcus hominis strain MBL_AB63 produces a novel lantibiotic, homicorcin and a position one variant. | Aftab Uddin M, Akter S, Ferdous M, Haidar B, Amin A, Shofiul Islam Molla AHM, Khan H, Islam MR | Sci Rep | 10.1038/s41598-021-90613-9 | 2021 | |
| Genetics | Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems. | Muller A, Grein F, Otto A, Gries K, Orlov D, Zarubaev V, Girard M, Sher X, Shamova O, Roemer T, Francois P, Becher D, Schneider T, Sahl HG | Int J Med Microbiol | 10.1016/j.ijmm.2017.12.002 | 2017 | |
| Metabolism | Structural Basis for Xenosiderophore Utilization by the Human Pathogen Staphylococcus aureus. | Endicott NP, Lee E, Wencewicz TA | ACS Infect Dis | 10.1021/acsinfecdis.7b00036 | 2017 | |
| Pathogenicity | Development of in vitro resistance to chitosan is related to changes in cell envelope structure of Staphylococcus aureus. | Raafat D, Leib N, Wilmes M, Francois P, Schrenzel J, Sahl HG | Carbohydr Polym | 10.1016/j.carbpol.2016.09.075 | 2016 | |
| Metabolism | Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus. | Wencewicz TA, Long TE, Mollmann U, Miller MJ | Bioconjug Chem | 10.1021/bc300610f | 2013 | |
| Pathogenicity | Antimicrobial phenalenone derivatives from the marine-derived fungus Coniothyrium cereale. | Elsebai MF, Kehraus S, Lindequist U, Sasse F, Shaaban S, Gutschow M, Josten M, Sahl HG, Konig GM | Org Biomol Chem | 10.1039/c0ob00625d | 2010 | |
| Genetics | Native graS mutation supports the susceptibility of Staphylococcus aureus strain SG511 to antimicrobial peptides. | Sass P, Bierbaum G | Int J Med Microbiol | 10.1016/j.ijmm.2008.10.005 | 2009 | |
| Pathogenicity | Insights into the mode of action of chitosan as an antibacterial compound. | Raafat D, von Bargen K, Haas A, Sahl HG | Appl Environ Microbiol | 10.1128/AEM.00453-08 | 2008 | |
| Pathogenicity | Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. | Sass V, Pag U, Tossi A, Bierbaum G, Sahl HG | Int J Med Microbiol | 10.1016/j.ijmm.2008.01.011 | 2008 | |
| Pathogenicity | Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'. | Pag U, Oedenkoven M, Sass V, Shai Y, Shamova O, Antcheva N, Tossi A, Sahl HG | J Antimicrob Chemother | 10.1093/jac/dkm479 | 2008 | |
| Pathogenicity | Volsurf analysis of carbapenem antibiotics. | Doddareddy MR, Cha JH, Cho YS, Koh HY, Yoo KH, Kim DJ, Pae AN | Bioorg Med Chem | 10.1016/j.bmc.2005.03.018 | 2005 | |
| Metabolism | Staphylococcus aureus penicillin-binding protein 4 and intrinsic beta-lactam resistance. | Henze UU, Berger-Bachi B | Antimicrob Agents Chemother | 10.1128/AAC.39.11.2415 | 1995 | |
| Enzymology | Antibacterial phenylpropanoid glycosides from Paulownia tomentosa Steud. | Kang KH, Jang SK, Kim BK, Park MK | Arch Pharm Res | 10.1007/BF02979128 | 1994 | |
| Metabolism | RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins. | Markus A, Klesel N, Wollmann T, Isert D, Limbert M, Schrinner E, Seibert G, Bauernfeind A, Jungwirth R, Wilhelm R, et al. | J Antibiot (Tokyo) | 10.7164/antibiotics.45.521 | 1992 | |
| Metabolism | A novel labeling procedure of anteiso-fatty acid-containing lipids in staphylococci for investigating the effect of penicillin on lipid release. | Rozgonyi F, Hahn H, Labischinski H, Giesbrecht P | FEMS Microbiol Lett | 10.1016/0378-1097(90)90024-k | 1990 | |
| [The disposition and clearance of inhaled bacteria (Staphylococcus aureus) in the lungs of piglets]. | Kastner P, Mehlhorn G | Arch Exp Veterinarmed | 1989 | | ||
| Pathogenicity | [Microbiologic studies of the lung clearance of rats after aerogenous long term exposure to ammonia]. | Kastner P, Mehlhorn G | Arch Exp Veterinarmed | 1989 | | |
| Pathogenicity | [Escape of hydrogen peroxide and oxygen from the root canal]. | Glockmann E, Oehring H, Hoffmann B, Lange G, Weisser G, Wunderlich I | Zahn Mund Kieferheilkd Zentralbl | 1989 | | |
| Pathogenicity | Synthesis and structure-activity relationships in the cefpirome series. I. 7-[2-(2-Aminothiazol-4-yl)-2-(Z)-oxyiminoacetamido]-3-[(su bstituted-1-pyridinio)methyl]ceph-3-em-4-carboxylate s. | Lattrell R, Blumbach J, Duerckheimer W, Fehlhaber HW, Fleischmann K, Kirrstetter R, Mencke B, Scheunemann KH, Schrinner E, Schwab W, et al. | J Antibiot (Tokyo) | 10.7164/antibiotics.41.1374 | 1988 | |
| Enzymology | Bovine leukocyte phagocytosis and bacteria killing monitored by intracellular acridine orange fluorescence and extracellular fluorescence quenching. | Zanetti M, Schmitt M, Lazary S | Vet Immunol Immunopathol | 10.1016/0165-2427(87)90017-1 | 1987 | |
| Pathogenicity | [Effect of colchicine and indomethacin on leukocytic phagocytosis of Staphylococcus aureus and E. coli]. | Schleef H, Stelzner A, Kunze M | Zentralbl Bakteriol Mikrobiol Hyg A | 1984 | | |
| Pathogenicity | [Studies on the mycotic and bacterial risk of contamination and the use of nipagin in the artificial insemination of cryosperm]. | Glander HG, Rytter M, Schonborn C | Zentralbl Gynakol | 1984 | | |
| Pathogenicity | [Effect of carrageenan, galactose and 2,4-dinitrophenol on leukocyte phagocytosis of Staphylococcus aureus and E. coli]. | Stelzner A, Schleef H, Kunze M | Allerg Immunol (Leipz) | 1984 | | |
| Enzymology | Microbiological investigations on cryopreserved human semen. | Glander HJ, Schonborn C, Rytter M | Int J Androl | 10.1111/j.1365-2605.1983.tb00550.x | 1983 | |
| Pathogenicity | Measurements of nonspecific humoral immune parameters in patients with chronic pyelonephritis. | Stein G, Stelzner A | Clin Nephrol | 1981 | | |
| Pathogenicity | [The clinical value of unspecific humoral immune parameters. Attempt at an immunogram. II. Quantitative determination of CH50E, CB50E, C3, C4 and lysozyme and measurement of indirect phagocytosis rate in the serum of patients with chronic pyelonephritis]. | Stelzner A, Stein G, Kittlick M | Z Gesamte Inn Med | 1979 | | |
| Pathogenicity | Antimicrobial activity of tibezonium (TBZ). | Veronese M, Salvaterra M, Setnikar I | Chemotherapy | 10.1159/000221976 | 1977 | |
| Metabolism | Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes. | Dietrich A, Steffens U, Gajdiss M, Boschert AL, Droge JK, Szekat C, Sass P, Malik IT, Bornikoel J, Reinke L, Macek B, Franz-Wachtel M, Nieselt K, Harbig T, Scherlach K, Brotz-Oesterhelt H, Hertweck C, Sahl HG, Bierbaum G | Microbiol Spectr | 10.1128/spectrum.02567-22 | 2022 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive14456.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License